152 related articles for article (PubMed ID: 26910576)
1. PHOX2B Is Associated with Neuroblastoma Cell Differentiation.
Yang L; Ke XX; Xuan F; Tan J; Hou J; Wang M; Cui H; Zhang Y
Cancer Biother Radiopharm; 2016 Mar; 31(2):44-51. PubMed ID: 26910576
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel pathways and molecules able to down-regulate PHOX2B gene expression by in vitro drug screening approaches in neuroblastoma cells.
Di Zanni E; Fornasari D; Ravazzolo R; Ceccherini I; Bachetti T
Exp Cell Res; 2015 Aug; 336(1):43-57. PubMed ID: 25882494
[TBL] [Abstract][Full Text] [Related]
3. Distinct neuroblastoma-associated alterations of PHOX2B impair sympathetic neuronal differentiation in zebrafish models.
Pei D; Luther W; Wang W; Paw BH; Stewart RA; George RE
PLoS Genet; 2013 Jun; 9(6):e1003533. PubMed ID: 23754957
[TBL] [Abstract][Full Text] [Related]
4. PHOX2B is a suppressor of neuroblastoma metastasis.
Naftali O; Maman S; Meshel T; Sagi-Assif O; Ginat R; Witz IP
Oncotarget; 2016 Mar; 7(9):10627-37. PubMed ID: 26840262
[TBL] [Abstract][Full Text] [Related]
5. The role of β-catenin and paired-like homeobox 2B (PHOX2B) expression in neuroblastoma patients; predictive and prognostic value.
El-Shazly SS; Hassan NM; Abdellateif MS; El Taweel MA; Abd-Elwahab N; Ebeid EN
Exp Mol Pathol; 2019 Oct; 110():104272. PubMed ID: 31220430
[TBL] [Abstract][Full Text] [Related]
6. Mutations that disrupt PHOXB interaction with the neuronal calcium sensor HPCAL1 impede cellular differentiation in neuroblastoma.
Wang W; Zhong Q; Teng L; Bhatnagar N; Sharma B; Zhang X; Luther W; Haynes LP; Burgoyne RD; Vidal M; Volchenboum S; Hill DE; George RE
Oncogene; 2014 Jun; 33(25):3316-24. PubMed ID: 23873030
[TBL] [Abstract][Full Text] [Related]
7. Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR.
Druy AE; Shorikov EV; Tsaur GA; Popov AM; Zaychikov AN; Tuponogov SN; Saveliev LI; Tytgat GAM; Fechina LG
Pediatr Blood Cancer; 2018 Nov; 65(11):e27354. PubMed ID: 30007008
[TBL] [Abstract][Full Text] [Related]
8. Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study.
Viprey VF; Gregory WM; Corrias MV; Tchirkov A; Swerts K; Vicha A; Dallorso S; Brock P; Luksch R; Valteau-Couanet D; Papadakis V; Laureys G; Pearson AD; Ladenstein R; Burchill SA
J Clin Oncol; 2014 Apr; 32(10):1074-83. PubMed ID: 24590653
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries.
Boeva V; Louis-Brennetot C; Peltier A; Durand S; Pierre-Eugène C; Raynal V; Etchevers HC; Thomas S; Lermine A; Daudigeos-Dubus E; Geoerger B; Orth MF; Grünewald TGP; Diaz E; Ducos B; Surdez D; Carcaboso AM; Medvedeva I; Deller T; Combaret V; Lapouble E; Pierron G; Grossetête-Lalami S; Baulande S; Schleiermacher G; Barillot E; Rohrer H; Delattre O; Janoueix-Lerosey I
Nat Genet; 2017 Sep; 49(9):1408-1413. PubMed ID: 28740262
[TBL] [Abstract][Full Text] [Related]
10. Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation.
Newman EA; Chukkapalli S; Bashllari D; Thomas TT; Van Noord RA; Lawlor ER; Hoenerhoff MJ; Opipari AW; Opipari VP
Cell Death Dis; 2017 Dec; 8(12):3208. PubMed ID: 29238067
[TBL] [Abstract][Full Text] [Related]
11. Phox2B correlates with MYCN and is a prognostic marker for neuroblastoma development.
Ke XX; Zhang D; Zhao H; Hu R; Dong Z; Yang R; Zhu S; Xia Q; Ding HF; Cui H
Oncol Lett; 2015 Jun; 9(6):2507-2514. PubMed ID: 26137098
[TBL] [Abstract][Full Text] [Related]
12. Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis.
Corrias MV; Parodi S; Tchirkov A; Lammens T; Vicha A; Pasqualini C; Träger C; Yáñez Y; Dallorso S; Varesio L; Luksch R; Laureys G; Valteau-Couanet D; Canete A; Pöetschger U; Ladenstein R; Burchill SA
Pediatr Blood Cancer; 2018 Jul; 65(7):e27052. PubMed ID: 29603574
[TBL] [Abstract][Full Text] [Related]
13. Neuroblastoma phox2b variants stimulate proliferation and dedifferentiation of immature sympathetic neurons.
Reiff T; Tsarovina K; Majdazari A; Schmidt M; del Pino I; Rohrer H
J Neurosci; 2010 Jan; 30(3):905-15. PubMed ID: 20089899
[TBL] [Abstract][Full Text] [Related]
14. Phox2B mutations and the Delta-Notch pathway in neuroblastoma.
van Limpt V; Chan A; Schramm A; Eggert A; Versteeg R
Cancer Lett; 2005 Oct; 228(1-2):59-63. PubMed ID: 16084642
[TBL] [Abstract][Full Text] [Related]
15. Autonomic neurocristopathy-associated mutations in PHOX2B dysregulate Sox10 expression.
Nagashimada M; Ohta H; Li C; Nakao K; Uesaka T; Brunet JF; Amiel J; Trochet D; Wakayama T; Enomoto H
J Clin Invest; 2012 Sep; 122(9):3145-58. PubMed ID: 22922260
[TBL] [Abstract][Full Text] [Related]
16. Lung-residing metastatic and dormant neuroblastoma cells.
Edry Botzer L; Maman S; Sagi-Assif O; Meshel T; Nevo I; Bäuerle T; Yron I; Witz IP
Am J Pathol; 2011 Jul; 179(1):524-36. PubMed ID: 21703429
[TBL] [Abstract][Full Text] [Related]
17. Highly sensitive assessment of neuroblastoma minimal residual disease in ovarian tissue using RT-qPCR-A strategy for improving the safety of fertility restoration.
Grèze V; Brugnon F; Chambon F; Halle P; Canis M; Amiot C; Grémeau AS; Pereira B; Yáñez Peralta Y; Tchirkov A; Kanold J
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27734578
[TBL] [Abstract][Full Text] [Related]
18. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
19. Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma.
Cazes A; Lopez-Delisle L; Tsarovina K; Pierre-Eugène C; De Preter K; Peuchmaur M; Nicolas A; Provost C; Louis-Brennetot C; Daveau R; Kumps C; Cascone I; Schleiermacher G; Prignon A; Speleman F; Rohrer H; Delattre O; Janoueix-Lerosey I
Oncotarget; 2014 May; 5(9):2688-702. PubMed ID: 24811913
[TBL] [Abstract][Full Text] [Related]
20. Low spinophilin expression enhances aggressive biological behavior of breast cancer.
Schwarzenbacher D; Stiegelbauer V; Deutsch A; Ress AL; Aigelsreiter A; Schauer S; Wagner K; Langsenlehner T; Resel M; Gerger A; Ling H; Ivan C; Calin GA; Hoefler G; Rinner B; Pichler M
Oncotarget; 2015 May; 6(13):11191-202. PubMed ID: 25857299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
